Others showed that RAGE activation, triggered by S100A4, decreased BMPR2-PPARγ signaling in PASMCs from PAH patients through the activation of STAT3, and thus induced PASMC proliferation and resistance to apoptosis [18,35]. Here, STAT3 is linked to pulmonary arterial hypertension.